Overview

ZD03 Capsule Study

Status:
Completed

Trial end date:
2020-04-27

Target enrollment:

Participant gender:

Summary

This is a Phase 1, Double Blind, Randomized, Placebo Controlled, Single Dose, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZD03 Capsule in Healthy Volunteers in The United States

Phase:

Phase 1

Details

Lead Sponsor:

Shanxi Zhendong Leading Biotechnology Co., Ltd.